Related Experiment Videos
Molecular and reconstructive urology: a coming together.
1Department of Surgery, University of Queensland, Royal Brisbane Hospital, Herston, Australia. f.gardiner@mailbox.uq.edu.au
World Journal of Surgery
|November 9, 2000
Summary
Advances in prostate-specific antigen (PSA) testing enable earlier prostate cancer diagnosis, leading to improved surgical techniques. Ongoing molecular research aims to enhance reconstructive urologic surgery and patient outcomes beyond the year 2000.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Men's help-seeking in the first year after diagnosis of localised prostate cancer.
European journal of cancer care·2016
Same author
The global burden of major infectious complications following prostate biopsy.
Epidemiology and infection·2015
Same author
Financial toxicity: a potential side effect of prostate cancer treatment among Australian men.
European journal of cancer care·2015